v3.25.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Revenues:        
Total revenues $ 15,328 $ 7,979 $ 22,871 $ 25,052
Costs and operating expenses:        
Cost of product revenue 2,098 3,462 4,830 8,317
Research and development 13,775 11,413 26,717 22,659
Selling, general and administrative 12,317 15,671 24,672 28,531
Asset impairment and other charges 0 165 0 165
Total costs and operating expenses 28,190 30,711 56,219 59,672
Loss from operations (12,862) (22,732) (33,348) (34,620)
Interest income 584 972 1,335 1,881
Interest and other expense, net (984) (985) (1,926) (1,500)
Loss before income taxes (13,262) (22,745) (33,939) (34,239)
Provision for income taxes 10 10 21 21
Net loss $ (13,272) $ (22,755) $ (33,960) $ (34,260)
Net loss per share, basic (in dollars per share) $ (0.16) $ (0.32) $ (0.40) $ (0.49)
Net loss per share, diluted (in dollars per share) $ (0.16) $ (0.32) $ (0.40) $ (0.49)
Weighted average common stock shares used in computing net loss per share, basic (in shares) 85,389 70,376 83,908 70,115
Weighted average common stock shares used in computing net loss per share, diluted (in shares) 85,389 70,376 83,908 70,115
Product revenue        
Revenues:        
Total revenues $ 7,380 $ 6,259 $ 13,439 $ 15,810
Research and development revenue        
Revenues:        
Total revenues $ 7,948 $ 1,720 $ 9,432 $ 9,242

Source